THCA is not classified as a controlled substance in North Dakota, so it is legally permissible to possess, sell, and consume raw cannabis material that contains the non‑psychoactive acid. However, the 2026 amendment to the state’s hemp‑derived cannabinoid statute introduced specific testing and labeling requirements that affect how THCA products must be marketed and sold.
Current Legal Status of THCA in North Dakota
North Dakota’s cannabis framework distinguishes between “marijuana” (the dried flower) and “hemp‑derived cannabinoids.” Under the 2022 Medical Cannabis Statute (N.D. Century Code §§ 47‑01‑01 to 47‑01‑12) only products containing Δ⁹‑tetrahydrocannabinol (THC) above 0.3 % are prohibited. THCA, the acidic precursor to THC, does not produce intoxication until it is decarboxylated by heat. Consequently, raw plant material and extracts that retain THCA are treated as hemp‑derived products and are legal, provided the THC‑acid content does not exceed the 0.3 % threshold after testing.
What Changed in 2026
In early 2026 the North Dakota Legislature passed SB 215, amending the Hemp‑Derived Cannabinoid Regulation Act. The key provisions are:
- Mandatory third‑party laboratory analysis for THCA concentration on all packaged products.
- A ceiling of 20 % THCA by weight for consumer‑grade products; anything higher is classified as “high‑potency” and may only be sold to licensed medical‑cannabis dispensaries.
- Required clear labeling that distinguishes THCA from Δ⁹‑THC, includes the exact percentage, and warns that heating will convert THCA to THC.
- Penalties for non‑compliance increased to up to $2,500 per violation or suspension of the retailer’s license.
These measures were intended to prevent inadvertent intoxication and to align state law with federal hemp regulations clarified by the 2022 Farm Bill interpretation.
Implications for Consumers and Businesses
For consumers, the 2026 rules mean greater transparency: a product labeled “THCA oil 15 %” must have an independent certificate of analysis confirming the figure. Users who prefer non‑psychoactive effects can now verify that their product stays below the 20 % limit.
For businesses, the new testing requirement adds cost but also creates a competitive advantage for firms that can provide verified, compliant products. Retailers must update inventory systems to track certification numbers and ensure that any product exceeding 20 % THCA is routed exclusively to licensed medical dispensaries.
Key Takeaways
- THCA is legal in North Dakota as long as it remains a hemp‑derived cannabinoid and complies with the 0.3 % THC limit.
- The 2026 amendment imposes testing, labeling, and potency caps that reshape the market.
- Consumers gain clearer information, while businesses face additional compliance obligations.
Is THCA considered a controlled substance under North Dakota law?
No. THCA is categorized under hemp‑derived cannabinoids, not under the controlled‑substance schedule, provided the THC‑acid content remains below the statutory limit.
Can I sell THCA products without a medical cannabis license?
Yes, if the product contains 20 % THCA or less and meets the testing and labeling standards introduced in 2026. Higher‑potency THCA requires a medical dispensary license.
Do I need to test every batch of THCA product?
All consumer‑grade THCA products must be tested by an accredited third‑party lab for cannabinoid concentration before they can be labeled and sold.
What penalties apply for non‑compliance with the 2026 rules?
Violations can result in fines up to $2,500 per incident and may lead to suspension or revocation of the retailer’s license depending on the severity.
How can I verify that a THCA product is compliant?
Look for a certificate of analysis attached to the packaging or accessible via a QR code, confirming the exact THCA percentage and that the product meets the 20 % potency cap